Chinese Journal of Pharmaceuticals
|
2023, 54(9): 1391-1395
• Pharmaceutical Management & Information •
Comprehensive Analysis of Warning Letters Issued by FDA to Chinese and Indian Pharmaceutical Enterprises: from 2016 to 2020
Full
Zhaozeng CHEN, Yifan XIA, Hui LI
*
Affiliations
- Center for Drug Safety Evaluation, School of Pharmacy, Zhejiang University, Hangzhou 310058
Published: 2023-09-10
doi: 10.16522/j.cnki.cjph.2023.09.017
Outline
陈钊锃, 夏逸凡, 李慧.
2016至2020年美国FDA对中国、印度制药企业所发警告信的综合分析.
中国医药工业杂志,
2023
, 54
(9)
: 1391
-1395
.
DOI: 10.16522/j.cnki.cjph.2023.09.017
Zhaozeng CHEN, Yifan XIA, Hui LI.
Comprehensive Analysis of Warning Letters Issued by FDA to Chinese and Indian Pharmaceutical Enterprises: from 2016 to 2020[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(9)
: 1391
-1395
.
DOI: 10.16522/j.cnki.cjph.2023.09.017
Year 2023 volume 54 Issue 9
22
4
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.09.017
- Receive Date:2022-07-08
- Online Date:2026-11-19
- Published:2023-09-10